The first phase 3 trials are due to start in the first half of next year, using devices manufactured at GSK’s facility in Evreux, France. “If successful, this could lead to regulatory ...

Its Covid vaccine, which is being developed with France's Sanofi, is still undergoing trials. GSK boss Emma Walmsley is selling the company's consumer healthcare division, which makes big-brand ...

British pharmaceutical company GSK on Monday said it had agreed to buy a US company that specialises in the treatment of rare gastrointestinal cancer GIST.